top of page
pharma naming
The Readge blog
Looking to navigate the complex world of drug naming with more confidence? The Readge Blog offers sharp insights into regulatory naming—from INN and brand name approval to risk management and portfolio strategies.
You’ll find:
-
Practical tips for avoiding rejection by EMA, FDA and WHO
-
World wide examples of what works (and what doesn’t)
-
Strategies for building a strong, compliant name system
-
Articles and perspectives from experts around the world
Whether you're naming your first product or managing an entire portfolio, our blog gives you useful and instructive information.
Search
Hanmi's $200M China plant likely to make branded drugs versus generics
South Korean drug manufacturer Hanmi is building a $200 million manufacturing plant and R&D center in China, though it won't, apparently,...
pharmanaming.com by Readge consultants
2 min read
Top three therapy areas dominate pipelines
The world's top three therapy areas accounted for 68 percent of the overall pharmaceutical industry pipeline as of Q1 2016, according to...
pharmanaming.com by Readge consultants
2 min read
GSK teams up with Google on bioelectronic medicines
GlaxoSmithKline is teaming up with Google's parent company Alphabet to create a new company focused on developing bioelectronic...
pharmanaming.com by Readge consultants
2 min read
Value-based care necessitates big changes for pharma marketers, says digital pharma agency
Much has been discussed, and some dismissed, when it comes to value-based care in the pharma industry. However, no one can deny that the...
pharmanaming.com by Readge consultants
2 min read
India’s Drug Approvals Near Record Despite FDA Inspection Blitz
Even as the FDA has increased scrutiny of India, it’s been approving generic drug applications from the country’s firms at a record pace....
pharmanaming.com by Readge consultants
3 min read
With a Name Like Xalkori
New drug names aren’t just bizarre—they’re dangerous. What would Don Draper make of Xalkori? Pfizer’s lung cancer drug, released in 2011,...
pharmanaming.com by Readge consultants
2 min read
How does a drug get its name?
Street names aside, who comes up with crazy non-words like Zyrtec, Tenofovir and Xeljanz? Say it with me: Xeljanz. OK, at least try and...
pharmanaming.com by Readge consultants
3 min read
How the Nurofen Specific Pain Range marketing strategy was undone as misleading by the Australian AC
It was a brilliant marketing strategy … instead of marketing the fast-acting Nurofen for pain relief as one product effective for a range...
pharmanaming.com by Readge consultants
5 min read
Pharma product launch optimisation tool
Vivisum has launched Brand Builder, a solution that provides strategic market insight for pharmaceutical brands. Brand Builder combines...
pharmanaming.com by Readge consultants
1 min read
As biosims win nods in Europe and India, debate over naming rights heats up
From www.fiercepharma.com Drugmakers, biotechs and their generic rivals are squabbling over the names that will be assigned to...
pharmanaming.com by Readge consultants
3 min read
The FDA way
Ira Levy of Goodwin Procter discusses the FDA regulation for drug names and how companies can reduce their chances of rejection. What is...
pharmanaming.com by Readge consultants
5 min read
FDA Approves Zarxio, First Biosimilar Drug
The approval paves the way for alternatives to an entire class of complex and costly drugs to go on the market. Most brand-name drugs...
pharmanaming.com by Readge consultants
5 min read
Putting our lives in their brands
From www.theguardian.com What if brand loyalty was actually as serious as life and death? Nick Dutnall looks at how we might trust a...
pharmanaming.com by Readge consultants
3 min read
Making medicine emotional
from www.mmm-online.com Since the birth of branding, and particularly in the advent of the “like,” people have been using brands as a...
pharmanaming.com by Readge consultants
2 min read
Update on pharmaceutical brand name requirements in Canada
Sponsors filing a drug submission must also provide a brand name assessment as part of the drug safety and effectiveness evaluation. The...
pharmanaming.com by Readge consultants
2 min read
What's in a name? For drugs, a lot of Zs and Xs
Farxiga. Hetlioz. Otezla. Zykadia. No, these are not the names of distant planets visited by the starship Enterprise. They're the brand...
pharmanaming.com by Readge consultants
4 min read
Back-to-'Biogen' shift signals wider industry branding trend
Biogen's ($BIIB) recent change back to its original name - from the decade-old merger name Biogen Idec - made sense in many ways. Along...
pharmanaming.com by Readge consultants
2 min read
Cancer breakthroughs trigger big pharma interest in drugs and deals
Companies are scrambling to get into the immunotherapy market, which experts think could eventually be worth up to £26bn a year in sales....
pharmanaming.com by Readge consultants
3 min read
Defining brands and why they are critical to success in healthcare.
As we start our column in earnest, we thought we should perhaps state our position, be clear on some boundaries and definitions of what...
pharmanaming.com by Readge consultants
5 min read
The Science of Naming Drugs (Sorry, 'Z' Is Already Taken)
Not only is the process of christening a new product a lot trickier than it sounds, the most obvious candidates can be the most perilous....
pharmanaming.com by Readge consultants
4 min read
bottom of page